CASP9 and retinal ischemia: Using an integrated panel of ophthalmic imaging readouts, we evaluated the progression of retinal ischemia, edema, and neurodegeneration in wild-type mice treated with either a VEGF-neutralizing antibody or a topical caspase-9 inhibitor.